Familial Colorectal Cancer Type X
|
0.320 |
Biomarker
|
disease |
BEFREE |
Recent studies describe the correlation between FCCTX and genes such as BRCA2, SEMA4, NTS, RASSF9, GALNT12, KRAS, BRAF, APC, BMPR1A, and RPS20.
|
29096939 |
2018 |
Familial Colorectal Cancer Type X
|
0.320 |
GermlineCausalMutation
|
disease |
ORPHANET |
Evaluation of additional FCCX families for mutations in RPS20 and other ribosome-associated genes is warranted.
|
24941021 |
2014 |
Familial Colorectal Cancer Type X
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Evaluation of additional FCCX families for mutations in RPS20 and other ribosome-associated genes is warranted.
|
24941021 |
2014 |
Hereditary Nonpolyposis Colorectal Neoplasms
|
0.300 |
Biomarker
|
group |
CLINGEN |
Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.
|
27713038 |
2017 |
Hereditary non-polyposis colorectal cancer syndrome
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.
|
27713038 |
2017 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.
|
27713038 |
2017 |
Hereditary Non-Polyposis Colon Cancer Type 2
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.
|
27713038 |
2017 |
Colorectal cancer, hereditary nonpolyposis, type 1
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.
|
27713038 |
2017 |
Hereditary Nonpolyposis Colorectal Neoplasms
|
0.300 |
Biomarker
|
group |
CLINGEN |
Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency.
|
24941021 |
2014 |
Hereditary non-polyposis colorectal cancer syndrome
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency.
|
24941021 |
2014 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency.
|
24941021 |
2014 |
Hereditary Non-Polyposis Colon Cancer Type 2
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency.
|
24941021 |
2014 |
Colorectal cancer, hereditary nonpolyposis, type 1
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency.
|
24941021 |
2014 |
Malignant neoplasm of stomach
|
0.110 |
AlteredExpression
|
disease |
BEFREE |
Finally, the inverse correlation of GNL1 and RPS20 expression in primary colon and gastric cancers with patient survival strengthen their critical importance during tumorigenesis.
|
30061673 |
2018 |
Glioblastoma Multiforme
|
0.110 |
Biomarker
|
disease |
BEFREE |
The prognostic significance of RPS11 and RPS20 was further supported by whole tissue section RPS11 immunostaining (27 GBM; HR = 4.05, p = 0.01) and TCGA gene expression data (578 primary GBM; RPS11: HR = 1.19, p = 0.06; RPS20: HR = 1.25, p = 0.02; RPS11+RPS20: HR = 1.43, p = 0.01).
|
26506620 |
2015 |
Malignant neoplasm of stomach
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Glioblastoma Multiforme
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Lupus Erythematosus, Systemic
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Transancestral mapping and genetic load in systemic lupus erythematosus.
|
28714469 |
2017 |
Abdominal Pain
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Agnosia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Anxiety
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Colonic Neoplasms
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Constipation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dysarthria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|